ByTrending Posts
Can Verge Genomics’ AI-Powered VRG50635 Trial Redefine ALS…
Key Executive Takeaways Digital Biomarkers Show Disease Progression—Before Drug InterventionVerge Genomics has demonstrated that digital clinical biomarkers can…
Why Is insitro’s $25M Milestone with BMS a…
$25 Million Milestone Reached in Collaboration with Bristol Myers Squibb Unlocks First Novel ALS Target Key Highlights insitro…
Is insitro’s AI Collaboration with Moorfields Eye Hospital…
How 35 million eye scans and a new AI foundation model may redefine the future of precision medicine…
Can Valo Health and nference’s AI Alliance Reshape…
Key Insights for Industry Leaders A Strategic Union to Redefine Biopharma R&DValo Health and nference have joined forces…
How Are Charles River and Valo Health Leveraging…
Key Highlights:• Charles River and Valo Health identify the first Logica®-powered therapeutic candidate targeting lupus and autoimmune diseases…
How Pfizer and Flagship Pioneering Are Using AI…
Key Highlights Strategic Collaboration with a Transformative Goal Flagship Pioneering has announced a new collaboration between its in-house…
How Median Technologies AI Set to Transform Global…
Key Highlights AI-Powered Innovation in Oncology ImagingMedian Technologies, a pioneer in AI-driven medical imaging, will showcase its eyonis®…
NVIDIA CEO Jensen Huang Unveils Vision of a…
Key Highlights At COMPUTEX 2025 in Taipei, NVIDIA founder and CEO Jensen Huang revealed a groundbreaking vision positioning…
How LIS Technologies Is Advancing Medical Isotope Production…
Key Highlights Innovative CRISLA Technology to Impact Medical Therapies The company’s proprietary Condensation Repression Isotope Selective Laser Activation…
Trending Posts
Latest Stories
Did Oncology Approvals in 2025 Reshape the Competitive Landscape—and Set the Stage for a Breakthrough Cycle in 2026?
Global – December 2025 — The oncology sector reached a strategic inflection point in 2025,…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II Blood Cell Analyzer
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced…
Phase 3 Clinical Trials of Setrusumab in Osteogenesis Imperfecta Fail to Meet Primary Endpoints
London & Novato, Calif. — December 2025 Mereo BioPharma Group plc (NASDAQ: MREO) and Ultragenyx…
The Best Feeling Is When Our Drugs Succeed”: Dame Emma Walmsley Reflects on GSK’s Legacy of Innovation
London | December 2025 GlaxoSmithKline (GSK) today highlighted a defining reflection from its outgoing Chief…
Gallery
